Britain recommends not using Oxford/AstraZeneca vaccine for under-30s

Bywire will email you from time to time with news digests, stories & opportunities to get involved. Privacy .

LONDON - Britain's medicine regulator has identified a possible side-effect from COVID-19 vaccine developed by Oxford University and AstraZeneca involving rare brain blood clotting, chief executive June Raine said on Wednesday.

She added that its benefits outweighed the risks for the vast majority.

(Reporting by Alistair Smout; editing by James Davey)

Donate

Bywire will email you from time to time with news digests, stories & opportunities to get involved. Privacy .